SEC Form 3 · accession 0001209191-15-039650
aTYR PHARMA INC · LIFE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathryn E Falberg
Director
Period of report
May 6, 2015
Accepted (ET)
May 6, 2015 · 8:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001339970
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 12,572 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares of Common Stock are subject to the Issuer's right of repurchase, which lapses in 36 equal monthly installments beginning on June 1, 2014.
Remarks
Exhibit List Exhibit 24.1 - Power of Attorney